annual cash & cash equivalents:
$151.79M-$28.78M(-15.94%)Summary
- As of today (May 29, 2025), TECH annual cash & cash equivalents is $151.79 million, with the most recent change of -$28.78 million (-15.94%) on June 30, 2024.
- During the last 3 years, TECH annual cash & cash equivalents has fallen by -$47.30 million (-23.76%).
- TECH annual cash & cash equivalents is now -52.35% below its all-time high of $318.57 million, reached on June 30, 2014.
Performance
TECH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$140.67M-$36.88M(-20.77%)Summary
- As of today (May 29, 2025), TECH quarterly cash & cash equivalents is $140.67 million, with the most recent change of -$36.88 million (-20.77%) on March 31, 2025.
- Over the past year, TECH quarterly cash & cash equivalents has increased by +$755.00 thousand (+0.54%).
- TECH quarterly cash & cash equivalents is now -55.84% below its all-time high of $318.57 million, reached on June 30, 2014.
Performance
TECH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TECH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.9% | +0.5% |
| 3 y3 years | -23.8% | -12.5% |
| 5 y5 years | +50.5% | -9.9% |
TECH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.8% | at low | -25.0% | +10.5% |
| 5 y | 5-year | -23.8% | +50.5% | -33.6% | +10.5% |
| alltime | all time | -52.4% | >+9999.0% | -55.8% | >+9999.0% |
TECH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $140.67M(-20.8%) |
| Dec 2024 | - | $177.55M(-5.3%) |
| Sep 2024 | - | $187.54M(+23.6%) |
| Jun 2024 | $151.79M(-15.9%) | $151.79M(+8.5%) |
| Mar 2024 | - | $139.91M(+7.5%) |
| Dec 2023 | - | $130.13M(-12.5%) |
| Sep 2023 | - | $148.66M(-17.7%) |
| Jun 2023 | $180.57M(+4.6%) | $180.57M(+41.9%) |
| Mar 2023 | - | $127.28M(-22.7%) |
| Dec 2022 | - | $164.68M(-0.3%) |
| Sep 2022 | - | $165.26M(-4.2%) |
| Jun 2022 | $172.57M(-13.3%) | $172.57M(+7.3%) |
| Mar 2022 | - | $160.82M(-24.1%) |
| Dec 2021 | - | $211.84M(+7.9%) |
| Sep 2021 | - | $196.32M(-1.4%) |
| Jun 2021 | $199.09M(+35.8%) | $199.09M(+7.0%) |
| Mar 2021 | - | $186.14M(+12.5%) |
| Dec 2020 | - | $165.53M(-2.3%) |
| Sep 2020 | - | $169.40M(+15.5%) |
| Jun 2020 | $146.63M(+45.3%) | $146.63M(-6.1%) |
| Mar 2020 | - | $156.22M(+41.6%) |
| Dec 2019 | - | $110.29M(+10.4%) |
| Sep 2019 | - | $99.89M(-1.0%) |
| Jun 2019 | $100.89M(-17.3%) | $100.89M(+5.6%) |
| Mar 2019 | - | $95.56M(+11.3%) |
| Dec 2018 | - | $85.89M(-9.3%) |
| Sep 2018 | - | $94.67M(-22.4%) |
| Jun 2018 | $121.99M(+33.2%) | $121.99M(+40.9%) |
| Mar 2018 | - | $86.61M(-28.7%) |
| Dec 2017 | - | $121.46M(+67.6%) |
| Sep 2017 | - | $72.46M(-20.9%) |
| Jun 2017 | $91.61M(+42.6%) | $91.61M(+53.1%) |
| Mar 2017 | - | $59.84M(+1.5%) |
| Dec 2016 | - | $58.94M(-15.3%) |
| Sep 2016 | - | $69.59M(+8.3%) |
| Jun 2016 | $64.24M(+17.8%) | $64.24M(-2.2%) |
| Mar 2016 | - | $65.71M(+5.2%) |
| Dec 2015 | - | $62.45M(+27.9%) |
| Sep 2015 | - | $48.84M(-10.4%) |
| Jun 2015 | $54.53M(-82.9%) | $54.53M(-48.8%) |
| Mar 2015 | - | $106.45M(+14.5%) |
| Dec 2014 | - | $92.97M(-5.4%) |
| Sep 2014 | - | $98.24M(-69.2%) |
| Jun 2014 | $318.57M(+94.5%) | $318.57M(+157.7%) |
| Mar 2014 | - | $123.60M(+25.6%) |
| Dec 2013 | - | $98.40M(+17.3%) |
| Sep 2013 | - | $83.86M(-48.8%) |
| Jun 2013 | $163.79M(+40.4%) | $163.79M(+8.7%) |
| Mar 2013 | - | $150.71M(+5.2%) |
| Dec 2012 | - | $143.29M(+9.5%) |
| Sep 2012 | - | $130.81M(+12.1%) |
| Jun 2012 | $116.67M(+50.3%) | $116.67M(+22.5%) |
| Mar 2012 | - | $95.28M(+17.6%) |
| Dec 2011 | - | $80.99M(+2.2%) |
| Sep 2011 | - | $79.23M(+2.1%) |
| Jun 2011 | $77.61M(-17.6%) | $77.61M(-51.1%) |
| Mar 2011 | - | $158.63M(+16.7%) |
| Dec 2010 | - | $135.88M(+18.1%) |
| Sep 2010 | - | $115.01M(+22.2%) |
| Jun 2010 | $94.14M(-41.5%) | $94.14M(-13.0%) |
| Mar 2010 | - | $108.24M(-44.7%) |
| Dec 2009 | - | $195.55M(+11.9%) |
| Sep 2009 | - | $174.76M(+8.6%) |
| Jun 2009 | $160.94M(-3.6%) | $160.94M(+20.3%) |
| Mar 2009 | - | $133.82M(+11.9%) |
| Dec 2008 | - | $119.59M(-26.2%) |
| Sep 2008 | - | $162.07M(-2.9%) |
| Jun 2008 | $166.99M(+23.3%) | $166.99M(+2.5%) |
| Mar 2008 | - | $162.85M(+9.5%) |
| Dec 2007 | - | $148.66M(+2.7%) |
| Sep 2007 | - | $144.75M(+6.8%) |
| Jun 2007 | $135.49M | $135.49M(+16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $116.28M(+13.4%) |
| Dec 2006 | - | $102.56M(+4.8%) |
| Sep 2006 | - | $97.83M(+9.1%) |
| Jun 2006 | $89.63M(+11.6%) | $89.63M(+7.2%) |
| Mar 2006 | - | $83.60M(+21.6%) |
| Dec 2005 | - | $68.73M(-10.2%) |
| Sep 2005 | - | $76.52M(-4.8%) |
| Jun 2005 | $80.34M(+56.9%) | $80.34M(+34.5%) |
| Mar 2005 | - | $59.75M(-14.2%) |
| Dec 2004 | - | $69.63M(+11.9%) |
| Sep 2004 | - | $62.24M(+21.6%) |
| Jun 2004 | $51.20M(+30.0%) | $51.20M(-1.0%) |
| Mar 2004 | - | $51.73M(+7.8%) |
| Dec 2003 | - | $47.97M(+9.0%) |
| Sep 2003 | - | $44.02M(+11.8%) |
| Jun 2003 | $39.37M(+49.2%) | $39.37M(+46.7%) |
| Mar 2003 | - | $26.84M(-6.9%) |
| Dec 2002 | - | $28.82M(-12.3%) |
| Sep 2002 | - | $32.88M(+24.6%) |
| Jun 2002 | $26.39M(+24.1%) | $26.39M(+1.0%) |
| Mar 2002 | - | $26.14M(-13.1%) |
| Dec 2001 | - | $30.08M(+40.0%) |
| Sep 2001 | - | $21.48M(+1.0%) |
| Jun 2001 | $21.27M(+22.5%) | $21.27M(+14.2%) |
| Mar 2001 | - | $18.62M(+10.5%) |
| Dec 2000 | - | $16.86M(-20.7%) |
| Sep 2000 | - | $21.26M(+22.5%) |
| Jun 2000 | $17.36M(+35.6%) | $17.36M(-4.4%) |
| Mar 2000 | - | $18.16M(-2.9%) |
| Dec 1999 | - | $18.70M(+32.6%) |
| Sep 1999 | - | $14.10M(+10.2%) |
| Jun 1999 | $12.80M(-53.3%) | $12.80M(+13.3%) |
| Mar 1999 | - | $11.30M(-17.5%) |
| Dec 1998 | - | $13.70M(+29.2%) |
| Sep 1998 | - | $10.60M(-61.3%) |
| Jun 1998 | $27.40M(+218.6%) | $27.40M(+126.4%) |
| Mar 1998 | - | $12.10M(+22.2%) |
| Dec 1997 | - | $9.90M(+8.8%) |
| Sep 1997 | - | $9.10M(+5.8%) |
| Jun 1997 | $8.60M(+16.2%) | $8.60M(+59.3%) |
| Mar 1997 | - | $5.40M(-22.9%) |
| Dec 1996 | - | $7.00M(+25.0%) |
| Sep 1996 | - | $5.60M(-24.3%) |
| Jun 1996 | $7.40M(+39.6%) | $7.40M(+29.8%) |
| Mar 1996 | - | $5.70M(+39.0%) |
| Dec 1995 | - | $4.10M(-31.7%) |
| Sep 1995 | - | $6.00M(+13.2%) |
| Jun 1995 | $5.30M(-10.2%) | $5.30M(+1.9%) |
| Mar 1995 | - | $5.20M(+15.6%) |
| Dec 1994 | - | $4.50M(-25.0%) |
| Sep 1994 | - | $6.00M(+1.7%) |
| Jun 1994 | $5.90M(+47.5%) | $5.90M(+15.7%) |
| Mar 1994 | - | $5.10M(+50.0%) |
| Dec 1993 | - | $3.40M(0.0%) |
| Sep 1993 | - | $3.40M(-15.0%) |
| Jun 1993 | $4.00M(-11.1%) | $4.00M(+60.0%) |
| Mar 1993 | - | $2.50M(+19.0%) |
| Dec 1992 | - | $2.10M(-16.0%) |
| Sep 1992 | - | $2.50M(-44.4%) |
| Jun 1992 | $4.50M(+125.0%) | $4.50M(+15.4%) |
| Mar 1992 | - | $3.90M(+77.3%) |
| Dec 1991 | - | $2.20M(+22.2%) |
| Sep 1991 | - | $1.80M(-10.0%) |
| Jun 1991 | $2.00M(+53.8%) | $2.00M(+33.3%) |
| Mar 1991 | - | $1.50M(0.0%) |
| Dec 1990 | - | $1.50M(-28.6%) |
| Sep 1990 | - | $2.10M(+61.5%) |
| Jun 1990 | $1.30M(+30.0%) | $1.30M(-7.1%) |
| Mar 1990 | - | $1.40M(+75.0%) |
| Dec 1989 | - | $800.00K(-20.0%) |
| Sep 1989 | - | $1.00M |
| Jun 1989 | $1.00M | - |
FAQ
- What is Bio-Techne annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bio-Techne?
- What is Bio-Techne annual cash & cash equivalents year-on-year change?
- What is Bio-Techne quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Bio-Techne?
- What is Bio-Techne quarterly cash & cash equivalents year-on-year change?
What is Bio-Techne annual cash & cash equivalents?
The current annual cash & cash equivalents of TECH is $151.79M
What is the all time high annual cash & cash equivalents for Bio-Techne?
Bio-Techne all-time high annual cash & cash equivalents is $318.57M
What is Bio-Techne annual cash & cash equivalents year-on-year change?
Over the past year, TECH annual cash & cash equivalents has changed by -$28.78M (-15.94%)
What is Bio-Techne quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TECH is $140.67M
What is the all time high quarterly cash & cash equivalents for Bio-Techne?
Bio-Techne all-time high quarterly cash & cash equivalents is $318.57M
What is Bio-Techne quarterly cash & cash equivalents year-on-year change?
Over the past year, TECH quarterly cash & cash equivalents has changed by +$755.00K (+0.54%)